Virtual Reality vs Traditional Cognitive Training in Patients With Severe Acquired Brain Injury

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAnna Estraneo

About this trial

Considerable evidence exists for using Virtual Reality (VR) for rehabilitation of acquired brain injury (ABI), with a particular focus on stroke. However, to date very little evidence has been collected in patients with ABI with different aetiologies (i.e., traumatic or anoxic brain injury) and level of severity (i.e., severe, sABI). The present multicentre study aims to overcome current literature issues as heterogeneity of populations and outcomes, small sample sizes and a lack of randomized controlled trials, which can affect the level of evidence and generalizability of results, to determine the effectiveness of a non immersive VR-based rehabilitation versus traditional cognitive training (TCT).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

LCF ≥4 at study entry;

Age 18-75

Stable clinical diagnosis (i.e., stable LCF);

Time post-injury between 28 days and 6 months;

Disqualifiers

Severe medical conditions that might hamper participation in the rehabilitation sessions, or influence diagnosis;

Previous neurodegenerative or acquired neurological diseases that affect cognitive domains (e.g., dementia)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Khymeia®-Virtual Reality rehabilitation System (VRRS EVO SYSTEM or COMPACT VRRS ENGINE)

    Device

    fully immersive VR software created by clinicians and experts specialized in cognitive rehabilitation. Khymeia Devices are Medical Class 1 devices according to MDR. VRRS systems consist of a central process unit, complete with a capacitive touch screen LCD monitor.

  • Traditional cognitive training (TCT)

    Behavioral

    face-to-face approach between the therapist and the patient using paper and pencil tools and other traditional materials. The training of the executive abilities is carried out by working on categorization, planning, association processes, analogical reasoning, problem solving and coping strategies to simulate problematic situations, tailored on patients' deficits

Treatment groups

28 Participants
are divided into 2 treatment groups
Group A: Non-immersive VR-based training (VR)Experimental treatment 1 intervention
Group B: Traditional cognitive training (TCT)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Trail Making Test (B-A score)

The TMT is a neuropsychological test assessing executive functions. Higher scores indicate a better performance

Time frame
5 weeks

Secondary outcomes

1

Trail Making Test (B-A score)

The TMT is a neuropsychological test assessing executive functions. Higher scores indicate a better performance

Time frame
1 month after treatment
2

modified Barthel Index

It is a measure of functional disability, with higher scores indicating higher functional independence

Time frame
5 weeks - 1 month after treatment
3

Disability Rating Scale

It is a measure of functional disability, with higher scores indicating higher disability

Time frame
5 weeks - 1 month after treatment
4

System Usability Scale

It is a measure of usability and compliance. Higher scores indicate a better performance

Time frame
5 weeks - 1 month after treatment

Other outcomes

1

NeuroPsychiatric Inventory

It is a measure of neurobehavioural and psychiatric disorders. Higher scores indicate a more severe disorder

Time frame
5 weeks - 1 month after treatment
2

Level of Cognitive Functioning

A clinical scale assessing global cognitive functioning. Higher scores indicate a higher cognitive functioning

Time frame
5 weeks - 1 month after treatment
3

Galveston Orientation and Amnesia Test

A clinical measure of post-traumatic amnesia. Higher scores indicate a more severe amnesia

Time frame
5 weeks - 1 month after treatment
4

Oxford Cognitive Screening

A screening neuropsychological test assessing different cognitive domains. Higher scores indicate a better cognitive performance

Time frame
5 weeks - 1 month after treatment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Anna Estraneo

Lead sponsor

Fondazione Don Carlo Gnocchi Onlus

Sponsor institution

Istituti Clinici Scientifici Maugeri SpA

Collaborator

Ospedale Policlinico San Martino

Collaborator